Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH

Mathias B Møllerhøj, Sanne S Veidal, Kirstine Tølbøl Thrane, Denise Oró, Agnete Overgaard, Casper Gravesen Salinas, Martin Rønn Madsen, Larissa Pfisterer, Mogens Vyberg, Eric Simon, Andre Broermann, Niels Vrang, Jacob Jelsing, Michael Feigh, Henrik H Hansen*

*Kontaktforfatter

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

OriginalsprogEngelsk
TidsskriftClinical and translational science
Vol/bind15
Udgave nummer5
Sider (fra-til)1167-1186
Antal sider20
ISSN1752-8054
DOI
StatusUdgivet - maj 2022

Bibliografisk note

© 2022 Gubra. Clinical and Translational Science published by Wiley Periodicals LLC on behalf of American Society for Clinical Pharmacology and Therapeutics.

Fingeraftryk

Dyk ned i forskningsemnerne om 'Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH'. Sammen danner de et unikt fingeraftryk.

Citationsformater